A. Meireson

Randomized Phase 1 Trial of Pembrolizumab with Sequential Versus Concomitant Stereotactic Body Radiotherapy in Metastatic Urothelial Carcinoma.

E. Goetghebeur, A. Wyatt, K. Decaestecker, 2019, European urology.

Peritumoral endothelial indoleamine 2, 3-dioxygenase expression is an early independent marker of disease relapse in colorectal cancer and is influenced by DNA mismatch repair profile

E. Hulstaert, L. Brochez, P. Ost, 2018, Oncotarget.

Clinical Relevance of Serum Kyn/Trp Ratio and Basal and IFNγ-Upregulated IDO1 Expression in Peripheral Monocytes in Early Stage Melanoma

L. Brochez, N. Sundahl, P. Ost, 2021, Frontiers in Immunology.

Challenging PD-L1 expressing cytotoxic T cells as a predictor for response to immunotherapy in melanoma

L. Brochez, N. Sundahl, P. Ost, 2018, Nature Communications.